Potential of regulatory T cell-based therapies in the management of severe COVID-19 - Archive ouverte HAL Access content directly
Journal Articles European Respiratory Journal Year : 2020

Potential of regulatory T cell-based therapies in the management of severe COVID-19

(1) , (1) , (2) , (3) , (4) , (5)
1
2
3
4
5

Abstract

In view of dysregulated immune response, cytokine storm and inflammation-induced severe lung damage in severely ill COVID-19 patients, we propose that CD4+CD25+FoxP3+ regulatory T cell-based therapies could be considered for the patient management
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02879881 , version 1 (24-06-2020)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Emmanuel Stephen-Victor, Mrinmoy Das, Anupama Karnam, Bruno Pitard, Jean-François Gautier, et al.. Potential of regulatory T cell-based therapies in the management of severe COVID-19. European Respiratory Journal, 2020, ⟨10.1183/13993003.02182-2020⟩. ⟨inserm-02879881⟩
104 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More